Synucleins in synaptic plasticity and neurodegenerative disorders

Journal of Neuroscience Research

Volumn 58, Issue 1, 1999, Pages 120-129

  Clayton, David F ^b   George, Julia M ^a,b  

^a B107 Chem and Life Sci Laboratory   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Alzheimer's disease; Lewy body; Parkinson's disease; Phospholipase D; Songbird

Indexed keywords

ALPHA SYNUCLEIN; PHOSPHATIDIC ACID; PHOSPHOLIPASE D;

AGING; ALZHEIMER DISEASE; ARTICLE; DEGENERATIVE DISEASE; GENE MUTATION; LEWY BODY; LIPID VESICLE; NERVE CELL PLASTICITY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; SHY DRAGER SYNDROME; SYNAPTIC MEMBRANE;

ALPHA-SYNUCLEIN; ANIMALS; HUMANS; LEWY BODIES; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; PARKINSON DISEASE; SIGNAL TRANSDUCTION; SYNAPSES; SYNUCLEINS;

EID: 0033215063     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO;2-E     Document Type: Article

References (85)

1. Akopian AN, Wood JN. 1995. Peripheral nervous system-specific genes identified by subtractive cdna cloning. J Biol Chem 270:21264-21270.
2. Arai T, Ueda K, Ikeda K, Akiyama H, Haga C, Kondo H, Kuroki N, Niizato K, Iritani S, Tsuchiya K. 1999. Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/ alpha-synuclein. Neurosci Lett 259:83-86.
3. Arima K, Ueda K, Sunohara N, Arakawa K, Hirai S, Nakamura M, Tonozuka-Uehara H, Kawai M. 1998a. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol [Berl] 96:439-444.
4. Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, Tonozukauehara H, Kawai M. 1998b. Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of lewy bodies. Brain Res 808:93-100.
5. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T. 1998. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879-884.
6. Buchman VL, Adu J, Pinon LG, Ninkina NN, Davies AM. 1998a. Persyn, a member of the synuclein family, influences neurofilament network integrity. Nat Neurosci 1:101-103.
7. Buchman VL, Hunter HJA, Pinon LGP, Thompson J, Privalova EM, Ninkina NN, Davies AM. 1998b. Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system. J Neurosci 18:9335-9341.
8. Campion D, Martin C, Heilig R, Charbonnier F, Moreau V, Flaman JM, Petit JL, Hannequin D, Brice A, Frebourg T. 1995. The NACP/Synuclein gene - chromosomal assignment and screening for alterations in Alzheimer disease. Genomics 26:254-257.
9. Chen YG, Siddhanta A, Austin CD, Hammond SM, Sung TC, Frohman MA, Morris AJ, Shields D. 1997. Phospholipase D stimulates release of nascent secretory vesicles from the trans-Golgi network. J Cell Biol 138:495-504.
10. Clayton DF, George JM. 1998. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 21:249-254.
11. Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, Bar-Sagi D, Morris AJ, Frohman MA. 1997. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol 7:191-201.
12. Conway KA, Harper JD, Lansbury PT. 1998. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson-disease. Nature Med 4:1318-1320.
13. Crowther RA, Jakes R, Spillantini MG, Goedert M. 1998. Synthetic filaments assembled from c-terminally truncated alpha-synuclein. FEBS Lett 436:309-312.
14. Davidson WS, Jonas A, Clayton DF, George JM. 1998. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443-9449.
15. De Camilli P, Harris SM, Jr., Huttner WB, Greengard P. 1983. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. II. Its specific association with synaptic vesicles demonstrated by immunocytochemistry in agarose-embedded synaptosomes. J Cell Biol 96:1355-1373.
16. El-Agnaf OMA, Bodles AM, Guthrie DJS, Harriott P, Irvine GB. 1998a. The n-terminal region of Non-A-beta Component of Alzheimers-disease amyloid is responsible for its tendency to assume beta-sheet and aggregate. Eur J Biochem 258:157-163.
17. El-Agnaf OMA, Curran MD, Wallace A, Middleton D, Murgatroyd C, Curtis A, Perry R, Jaros E. 1998b. Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases. Neuroreport 9:3925-3927.
18. El-Agnaf OMA, Jakes R, Curran MD, Middleton D, Ingenito R, Bianchi E, Pessi A, Neill D, Wallace A. 1998c. Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett 440:71-75.
19. El-Agnaf OMA, Jakes R, Curran MD, Wallace A. 1998d. Effects of the mutations Ala(30) to Pro and Ala(53) to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease. FEBS Lett 440:67-70.
20. Exton JH. 1997. Phospholipase D: enzymology, mechanisms of regulation, and function. Physiol Rev 77:303-320.
21. Farrer M, Wavrant-De Vrieze F, Crook R, Boles L, Perez-Tur J, Hardy J, Johnson WG, Steele J, Maraganore D, Gwinn K, Lynch T. 1998. Low frequency of alpha-synuclein mutations in familial Parkinson's disease. Ann Neurol 43:394-397.
22. Frey U, Morris RGM. 1998. Synaptic tagging - implications for late maintenance of hippocampal long-term potentiation. Trends Neurosci 21:181-188.
23. George JM. 1993. Analysis of novel genes whose RNAs are enriched in the HVC-associated telencephalon of songbirds [Ph.D. thesis]. New York: Rockefeller University.
24. George JM, Clayton DF. 1998. Songbirds, synelfin and neurodegenerative disease. Neurosci News 1:12-17.
25. George JM, Jin H, Woods WS, Clayton DF. 1995. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361-372.
26. Giasson BI, Uryu K, Trojanowski JQ, Lee VMY. 1999. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 274:7619-7622.
27. Goedert M, Spillantini MG, Davies SW. 1998. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 8:619-632.
28. Han HY, Weinreb PH, Lansbury PT. 1995. The core Alzheimers peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid - is NAC a common trigger or target in neurodegenerative disease. Chem Biol 2:163-169.
29. Hashimoto M, Yoshimoto M, Sisk A, Hsu LJ, Sundsmo M, Kittel A, Saitoh T, Miller A, Masliah E. 1997. NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation. Biochem Biophys Res Commun 237:611-616.
30. Hashimoto M, Hsu LJ, Xia Y, Takeda A, Sisk A, Sundsmo M, Masliah E. 1999. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. NeuroReport 10:717-721.
31. Herrmann K, Arnold AP. 1991. The development of afferent projections to the robust archistriatal nucleus in male zebra finches: a quantitative electron microscopic study. J Neurosci 11:2063-2074.
32. Higuchi S, Arai H, Matsushita S, Matsui T, Kimpara T, Takeda A, Shirakura K. 1998. Mutation in the alpha-synuclein gene and sporadic Parkinsons-disease, Alzheimers-disease, and dementia with lewy bodies. Exp Neurol 153:164-166.
33. Ho SL, Kung MHW. 1998. G209a mutation in the alpha-synuclein gene is rare and not associated with sporadic Parkinsons-disease. Movement Dis 13:970-971.
34. Hu CJ, Sung SM, Liu HC, Chang JG. 1999. No mutation of G209A in the alpha-synuclein gene in sporadic Parkinson's disease among Taiwan Chinese. Eur Neurol 41:85-87.
35. Irizarry MC, Kim TW, McNamara M, Tanzi RE, George JM, Clayton DF, Hyman BT. 1996. Characterization of the precursor protein of the Non-A-beta Component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 55:889-895.
36. Irizarry MC, Growdon W, Gomezisla T, Newell K, George JM, Clayton DF, Hyman BT. 1998. Nigral and cortical lewy bodies and dystrophic nigral neuntes in Parkinsons-disease and cortical lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol 57:334-337.
37. Iseki E, Marui W, Kosaka K, Akiyama H, Ueda K, Iwatsubo T. 1998. Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease. Neurosci Lett 258: 81-84.
38. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, Rohan de Silva H, Kittel A, Saitoh T. 1995a. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14:467-475.
39. Iwai A, Yoshimoto M, Masliah E, Saitoh T. 1995b. Non-Aβ component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 34:10139-10145.
40. Jakes R, Spillantini MG, Goedert M. 1994. Identification of two distinct synucleins from human brain. FEBS Lett 345:27-32.
41. Jenco JM, Rawlingson A, Daniels B, Morris AJ. 1998. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha-and beta-synucleins. Biochemistry 37:4901-4909.
42. Jensen PH, Nielsen MS, Jakes R, Dotti G, Goedert M. 1998. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinsons-disease mutation. J Biol Chem 273:26292-26294.
43. Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, Joseph BK, Rosen C, Shi YE. 1997. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 57:759-764.
44. Jin H, Clayton DF. 1997. Synelfin regulation during the critical period for song learning in normal and isolated juvenile zebra finches. Neurobiol Learn Mem 68:271-284.
45. Kakizuka A. 1998. Protein precipitation - a common etiology in neurodegenerative disorders. Trends Genet Sci 14:396-402.
46. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O. 1998. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease [letter]. Nature Genet 18:106-108.
47. Lansbury PT. 1999. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci USA 96:3342-3344.
48. Lavedan C, Leroy E, Dehejia A, Buchholtz S, Dutra A, Nussbaum RL, Polymeropoulos MH. 1998. Identification, localization and characterization of the human gamma-synuclein gene. Hum Genet 103:106-112.
49. Lee JH, Shin HJ, Chang CS, Paik SR. 1998. Comparisons of the NACP self-oligomerizations induced by a-beta-25-35. Neurochem Res 23:1427-1434.
50. Lippa CF, Fujiwara H, Mann DMA, Giasson B, Baba M, Schmidt ML, Nee LE, O'Connell B, Pollen DA, George-Hyslop PS, Ghetti B, Nochlin D, Bird TD, Cairns NJ, Lee VMY, Iwatsubo T, Trojanowski JQ. 1998. Lewy bodies contain altered alpha-synuclein in brains of many familiar Alzheimers-disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 153:1365-1370.
51. Lippa CF, Schmidt ML, Lee VMY, Trojanowski JQ. 1999. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann Neurol 45:353-357.
52. Liu YB, Schubert D. 1998. Steroid hormones block amyloid fibril-induced 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (mtt) formazan exocytosis - relationship to neurotoxicity. J Neurochem 71:2322-2329.
53. Lucotte G, Mercier G, Turpin JC. 1998. Lack of mutation G209A in the alpha-synuclein gene in French patients with familial and sporadic Parkinson's disease. J Neurol Neurosurg Psychiatry 65:948-949.
54. Maroteaux L, Scheller RH. 1991. The rat brain synucleins: a family of proteins transiently associated with neuronal membrane. Mol Brain Res 11:335-343.
55. Maroteaux L, Campanelli JT, Scheller RH. 1988. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic terminal. J Neurosci 8:2804-2815.
56. Masliah E, Iwai A, Mallory M, Ueda K, Saitoh T. 1996. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Am J Pathol 148:201-210.
57. Mezey E, Dehejia AM, Harta G, Suchy SF, Nussbaum RL, Brownstein MJ, Polymeropoulos MH. 1998. Alpha synuclein is present in lewy bodies in sporadic Parkinsons-disease. Mol Psychiatry 3:493-499.
58. Nakajo S, Omato K, Aiuchi T, Shibayama T, Okahashi I, Ochiai H, Nakai Y, Nakaya K, Nakamura Y. 1990. Purification and characterization of a novel brain-specific 14-kDa protein. J Neurochem 55:2031-2038.
59. Nakajo S, Tsukada K, Omata K, Nakamura Y, Nakaya K. 1993. A new brain-specific 14-kDa protein is a phosphoprotein: its complete amino acid sequence and evidence for phosphorylation. Eur J Biochem 217:1057-1063.
60. Nakajo S, Shioda S, Nakai Y, Nakaya K. 1994. Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization. Mol Brain Res 27:81-86.
61. Nakajo S, Tsukada K, Kameyama H, Furuyama Y, Nakaya K. 1996. Distribution of phosphoneuroprotein 14 (PNP 14) in vertebrates: its levels as determined by enzyme immunoassay. Brain Res 741:180-184.
62. Narhi L, Wood SJ, Steavenson S, Jiang YJ, Wu GM, Anafi D, Kaufman SA, Martin F, Sitney K, Denis P, Louis JC, Wypych J, Biere AL, Citron M. 1999. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biol Chem 274:9843-9846.
63. Ninkina NN, Alimovakost MV, Paterson JWE, Delaney L, Cohen BB, Imreh S, Gnuchev NV, Davies AM, Buchman VL. 1998. Organization, expression and polymorphism of the human persyn gene. Hum Mol Genet 7:1417-1424.
64. Ninkina NN, Privalova EM, Pinon LGP, Davies AM, Buchman VL. 1999. Developmentally regulated expression of persyn, a member of the synuclein family, in skin. Exp Cell Res 246:308-311.
65. Parsian A, Racette B, Zhang ZH, Chakraverty S, Rundle M, Goate A, Perlmutter JS. 1998. Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease. Neurology 51:1757-1759.
66. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehijia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos S, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. 1997. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047.
67. Segrest J, Jones M, De Loof H, Brouillette C, Venkatachalapathi Y, Anantharamaiah G. 1992. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res 33:141-166.
68. Shibayama-Imazu T, Okahashi I, Omata K, Nakajo S, Ochiai H, Nakai Y, Hama T, Nakamura Y, Nakaya K. 1993. Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14). Brain Res 622:17-25.
69. Shibayama-Imazu T, Ogane K, Hasegawa Y, Nakajo S, Shioda S, Ochiai H, Nakai Y, Nakaya K. 1998. Distribution of pnp 14 (beta-synuclein) in neuroendocrine tissues - localization in sertoli cells. Mol Reprod Dev 50:163-169.
70. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M. 1997. Alpha-synuclein in Lewy bodies [scientific correspondence]. Nature 388:839-840.
71. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. 1998a. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinsons-disease and dementia with lewy bodies. Neurosci Lett 251:205-208.
72. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. 1998b. Alpha-synuclein in filamentous inclusions of lewy bodies from Parkinsons-disease and dementia with lewy bodies. Proc Natl Acad Sci USA 95:6469-6473.
73. Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E. 1998. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am J Pathol 152:367-372.
74. Takei K, McPherson PS, Schmid SL, De Camilli P. 1995. Tubular membrane invaginations coated by dynamin rings are induced by GTP-gamma S in nerve terminals [see comments]. Nature 374:186-190.
75. Trojanowski JQ, Goedert M, Iwatsubo T, Lee VMY. 1998. Fatal attractions - abnormal protein aggregation and neuron death in Parkinsons-disease and lewy body dementia. Cell Death Diff 5:832-837.
76. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero D, Kondo J, Ihara Y, Saitoh T. 1993. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci US A 90:11282-11286.
77. Vaughan J, Durr A, Tassin J, Bereznai B, Gasser T, Bonifati V, Demichele G, Fabrizio E, Volpe G, Bandmann O, Johnson WG, Golbe LI, Breteler M, Meco G, Agid Y, Brice A, Marsden CD, Wood NW. 1998. The alpha-synuclein ala53thr mutation is not a common cause of familial Parkinsons-disease - a study of 230 European cases. Ann Neurol 44:270-273.
78. Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H. 1997. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 239:45-48.
79. Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, Takahashi H. 1998a. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewybody disease and multiple system atrophy. Acta Neuropathol [Berl] 96:445-52.
80. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. 1998b. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180-182.
81. Wang WW, Khajavi M, Patel BJ, Beach J, Jankovic J, Ashizawa T. 1998. The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and/or Italian populations. Arch Neurol 55:1521-1523.
82. Warner TT, Schapira AHV. 1998. The role of the alpha-synuclein gene mutation in patients with sporadic Parkinsons-disease in the United Kingdom. J Neurol Neurosurg Psychiatry 65:378-379.
83. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PTJ. 1996. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35:13709-13715.
84. Withers G, George J, Banker G, Clayton DF. 1997. Delayed synaptic localization of synelfin/NACP compared to synaptic vesicle proteins in cultured rat hippocampal neurons. Dev Brain Res 99:87-94.
85. Yoshimoto M, Iwai A, Kang D, Otero DAC, Xia Y, Saitoh T. 1995. NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc Natl Acad Sci USA 92:9141-9145.